Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells
Open Access
- 1 December 1995
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 134 (1-2) , 108-114
- https://doi.org/10.1016/0022-510x(95)00231-0
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipidsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
- Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: Biochemical signs of combined sphingolipidosesEuropean Journal of Pediatrics, 1989
- Properties of acid ceramidase from human spleenBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Uptake and intracellular degradation of fluorescent sphingomyelin by fibroblasts from normal individuals and a patient with Niemann-Pick diseaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Acid and alkaline ceramidases of rat tissuesBiochemistry and Cell Biology, 1986
- Lysosomal involvement in cellular turnover of plasma membrane sphingomyelinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Phenotypic variability in siblings with Farber diseaseThe Journal of Pediatrics, 1984
- Partial Enzyme Deficiencies: Residual Activities and the Development of Neurological DisordersDevelopmental Neuroscience, 1983
- Diagnosis of lipogranulomatosis (Farber disease) by use of cultured fibroblastsThe Journal of Pediatrics, 1976
- The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tractBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1969